Biotech

All Articles

Lykos 'disappointments' certainly not making known research violations along with author

.Psychopharmacology has actually taken three short articles about midstage clinical trial informatio...

Analysts examine Avidity's DMD succeed, exposing distinctions in data

.Avidity Biosciences satisfied entrepreneurs along with stage 1/2 information in Duchenne muscle dys...

Actinogen's cortisol blocker falls short stage 2 anxiety research study

.Actinogen Medical's cortisol blocker has missed the key endpoint of a period 2 research in clinical...

Bivictrix makes a decision going personal only way to take ADC right into center

.Antibody-drug conjugates (ADCs) have actually been at the center of several a billion-dollar biobuc...

TPG bests up funds to $580M for investments around lifestyle scientific researches

.Asset supervisor TPG, which has actually sustained biotechs such as Sionna Rehabs as well as Santa ...

Merck ceases phase 3 TIGIT trial in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT plan has actually gone through yet another problem. Months after shuttering ...

After a difficult year, Exscientia folds up in to Recursion

.After a year specified through pipeline hairstyles, the departure of its CEO and also unemployments...

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Therapy was made an impression on good enough along with Port BioMed's bispecific immune a...

A closer check out Fierce Biotech's Tough 15

.In this week's episode of "The Top Line," our company're diving into Fierce Biotech's yearly Brutal...

Lilly faces period 2 breakdown of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's event celebrating the commendation of Alzhe...